Bitovir is generically known as Bic Enprenol Tablets and Jefcon is generically known as Ecco Enprenolone Tablets, both are medicines used for the treatment of HIV, but they are not comparable as they are indicated for slightly different populations. Bic Enprenol tablets are indicated for the treatment of adults with human immunodeficiency virus type 1 infection in whom there is no current or previous evidence of viral resistance to integrase inhibitor drugs, emtricitabine or tenofovir. Side effects usually manifest as nausea, vomiting, and diarrhea and can be tolerated in most cases. Ekornprevir tablets are covered by Medicare and are cost-effective for the less well-off patient population, with the disadvantages of a requirement to take them with food and a higher incidence of dyslipidemia. The product should be used with caution in people with hepatic impairment and those under 18 years of age. Compared to the non-nucleotide reverse transcriptase inhibitors (EFVs) that are often used nowadays, Gefuroxime, in addition to the rapid reduction in viral load, is more importantly characterized by a significant improvement in side effects, including allergies, dizziness, and other side effects that may interfere with daily life. Geflucan is effective in blocking the transmission of the infection, which can effectively block the HIV gene embedded in white blood cells to replicate, and can effectively control the infection. Usually, Jetivac is more effective when taken within 24 hours after high-risk behavior, and also has some blocking effect at 48 hours, but the blocking effect is usually weaker at 72 hours. The two drugs have their own benefits and side effects, and the specific choice of which to treat patients should not decide on their own, it is recommended that the use of drugs should be recommended by a doctor.